Enhanced levels of fractalkine and HSP60 in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients

References

• Harry GJ, Kraft AD. Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology. 2012;33(2):191–206. doi: 10.1016/j.neuro.2012.01.012.
   PubMed Web of Science ®Google Scholar
• Mishra PS, Vijayalakshmi K, Nalini A, et al. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia. J Neuroinflammation. 2017;14(1):251. doi: 10.1186/s12974-017-1028-x.
   PubMedGoogle Scholar
• Qin J, Ma Z, Chen X, et al. Microglia activation in central nervous system disorders: a review of recent mechanistic investigations and development efforts. Front Neurol. 2023;14:1103416. doi: 10.3389/fneur.2023.1103416.
   PubMed Web of Science ®Google Scholar
• Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004;1(1):14. doi: 10.1186/1742-2094-1-14.
   PubMed Web of Science ®Google Scholar
• Arnoux I, Audinat E. Fractalkine signaling and microglia functions in the developing brain. Neural Plast. 2015;2015:689404–689408. doi: 10.1155/2015/689404.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhao W, Guo Y, et al. CX3CL1/CX3CR1 in alzheimer’s disease: a target for neuroprotection. Biomed Res Int. 2016;2016:8090918. doi: 10.1155/2016/8090918.
   PubMed Web of Science ®Google Scholar
• Sokolowski JD, Chabanon-Hicks CN, Han CZ, et al. Fractalkine is a “find-me” signal released by neurons undergoing ethanol-induced apoptosis. Front Cell Neurosci. 2014;8:360. doi: 10.3389/fncel.2014.00360.
   PubMed Web of Science ®Google Scholar
• Suzuki M, El-Hage N, Zou S, et al. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 tat-induced dendritic losses and death. Mol Neurodegener. 2011;6(1):78. doi: 10.1186/1750-1326-6-78.
   PubMedGoogle Scholar
• Ślusarczyk J, Trojan E, Głombik K, et al. Fractalkine attenuates microglial cell activation induced by prenatal stress. Neural Plast. 2016;2016:7258201–7258211. doi: 10.1155/2016/7258201.
   PubMed Web of Science ®Google Scholar
• Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385(6617):640–644. doi: 10.1038/385640a0.
   PubMed Web of Science ®Google Scholar
• Jeyalan V, Austin D, Loh SX, et al. Fractalkine/CX3CR1 in dilated cardiomyopathy: a potential future target for immunomodulatory therapy? Cells. 2023;12(19):2377. doi: 10.3390/cells12192377.
   PubMed Web of Science ®Google Scholar
• Sullivan JC, Pardieck JL, Doran D, et al. Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males. Am J Physiol Heart Circ Physiol. 2009;296(4):H1080–8. doi: 10.1152/ajpheart.01093.2008.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bisht K, Tremblay MÈ. Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci. 2014;8:129. doi: 10.3389/fncel.2014.00129.
   PubMed Web of Science ®Google Scholar
• Chen X, He X, Xu F, et al. Fractalkine enhances hematoma resolution and improves neurological function via CX3CR1/AMPK/PPARγ pathway after GMH. Stroke. 2023;54(9):2420–2433. doi: 10.1161/STROKEAHA.123.043005.
   PubMed Web of Science ®Google Scholar
• Inoue K, Morimoto H, Ohgidani M, et al. Modulation of inflammatory responses by fractalkine signaling in microglia. PLoS One. 2021;16(5):e0252118. 21 doi: 10.1371/journal.pone.0252118.
   PubMed Web of Science ®Google Scholar
• Brites D, Vaz AR. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci. 2014; 8:117. doi: 10.3389/fncel.2014.00117.
   PubMed Web of Science ®Google Scholar
• Shobha K, Alladi PA, Nalini A, et al. Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100β expression. Neurosci Lett. 2010;473(1):56–61. doi: 10.1016/j.neulet.2010.02.022.
   PubMed Web of Science ®Google Scholar
• Valori CF, Brambilla L, Martorana F, et al. The multifaceted role of glial cells in amyotrophic lateral sclerosis. Cell Mol Life Sci. 2014;71(2):287–297. doi: 10.1007/s00018-013-1429-7.
   PubMed Web of Science ®Google Scholar
• Gorter RP, Stephenson J, Nutma E, et al. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes. Neuropathol Appl Neurobiol. 2019;45(5):459–475. doi: 10.1111/nan.12525.
   PubMed Web of Science ®Google Scholar
• Grundtman C, Kreutmayer SB, Almanzar G, et al. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(5):960–968. May doi: 10.1161/ATVBAHA.110.217877.
   PubMed Web of Science ®Google Scholar
• Ding F, Li F, Li Y, et al. HSP60 mediates the neuroprotective effects of curcumin by suppressing microglial activation. Exp Ther Med. 2016;12(2):823–828. doi: 10.3892/etm.2016.3413.
   PubMed Web of Science ®Google Scholar
• Lehnardt S, Schott E, Trimbuch T, et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci. 2008;28(10):2320–2331. doi: 10.1523/JNEUROSCI.4760-07.2008.
   PubMed Web of Science ®Google Scholar
• Bi F, Wang J, Zheng X, et al. HSP60 participates in the anti-glioma effects of curcumin. Exp Ther Med. 2021;21(3):204. doi: 10.3892/etm.2021.9637.
   PubMed Web of Science ®Google Scholar
• Liyanagamage DS, Martinus RD. Role of mitochondrial stress protein HSP60 in diabetes-induced neuroinflammation. Mediators Inflamm. 2020;2020:8073516–8073518. doi: 10.1155/2020/8073516.
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun L, Zhu H, et al. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity. Neurochem Int. 2012;61(7):1021–1035. doi: 10.1016/j.neuint.2012.07.019.
   PubMed Web of Science ®Google Scholar
• Swaroop S, Mahadevan A, Shankar SK, et al. HSP60 critically regulates endogenous IL-1β production in activated microglia by stimulating NLRP3 inflammasome pathway. J Neuroinflammation. 2018;15(1):177. doi: 10.1186/s12974-018-1214-5.
   PubMedGoogle Scholar
• Anneser JM, Chahli C, Borasio GD. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis–cerebrospinal fluid toxicity in vitro. Neuroscience. 2006;141(4):1879–1886. doi: 10.1016/j.neuroscience.2006.05.044.
   PubMed Web of Science ®Google Scholar
• Mishra PS, Dhull DK, Nalini A, et al. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflammation. 2016;13(1):212. doi: 10.1186/s12974-016-0698-0.
   PubMedGoogle Scholar
• Shahani N, Gourie-Devi M, Nalini A, et al. (-)-deprenyl alleviates the degenerative changes induced in the neonatal rat spinal cord by CSF from amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(3):172–179. doi: 10.1080/14660820410017037.
   PubMed Web of Science ®Google Scholar
• Shobha K, Vijayalakshmi K, Alladi PA, et al. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J Neurol Sci. 2007;254(1-2):9–16. doi: 10.1016/j.jns.2006.12.004.
   PubMed Web of Science ®Google Scholar
• Varghese AM, Ghosh M, Bhagat SK, et al. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation. J Neuroinflammation. 2020;17(1):232. doi: 10.1186/s12974-020-01909-y.
   PubMed Web of Science ®Google Scholar
• Steinacker P, Verde F, Fang L, et al. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. J Neurol Neurosurg Psychiatry. 2018;89(3):239–247. doi: 10.1136/jnnp-2017-317138.
   PubMed Web of Science ®Google Scholar
• Costa J, Gromicho M, Pronto-Laborinho A, et al. Cerebrospinal fluid chitinases as biomarkers for amyotrophic lateral sclerosis. Diagnostics. 2021;11(7):1210. doi: 10.3390/diagnostics11071210.
   Web of Science ®Google Scholar
• Bäckryd E, Lind AL, Thulin M, et al. High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls. Pain. 2017;158(12):2487–2495. doi: 10.1097/j.pain.0000000000001061.
   PubMed Web of Science ®Google Scholar
• Hatcher-Martin JM, McKay JL, Sommerfeld B, et al. Cerebrospinal fluid Aβ42 and fractalkine are associated with Parkinson’s disease with freezing of gait. medRxiv. 2020.
   Google Scholar
• Perea JR, Lleó A, Alcolea D, et al. Decreased CX3CL1 levels in the cerebrospinal fluid of patients with alzheimer’s disease. Front Neurosci. 2018;12:609. doi: 10.3389/fnins.2018.00609.
   PubMed Web of Science ®Google Scholar
• Campanella C, Pace A, Caruso Bavisotto C, et al. Heat shock proteins in alzheimer’s disease: role and targeting. Int J Mol Sci. 2018;19(9):2603. doi: 10.3390/ijms19092603.
   PubMed Web of Science ®Google Scholar
• Noelker C, Morel L, Osterloh A, et al. Heat shock protein 60: an endogenous inducer of dopaminergic cell death in parkinson disease. J Neuroinflammation. 2014;11(1):86. doi: 10.1186/1742-2094-11-86.
   PubMedGoogle Scholar
• Brooks BR, Miller RG, Swash M, et al. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–299. doi: 10.1080/146608200300079536.
   PubMed Web of Science ®Google Scholar
• Rancan M, Bye N, Otto VI, et al. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury. J Cereb Blood Flow Metab. 2004;24(10):1110–1118. doi: 10.1097/01.WCB.0000133470.91843.72.
   PubMed Web of Science ®Google Scholar
• Varghese AM, Sharma A, Mishra P, et al. Chitotriosidase-a putative biomarker for sporadic amyotrophic lateral sclerosis. Clin Proteomics. 2013;10(1):19. doi: 10.1186/1559-0275-10-19.
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez A, Gamez J, Syriani E, et al. CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis. PLoS One. 2014;9(5):e96528. doi: 10.1371/journal.pone.0096528.
   PubMed Web of Science ®Google Scholar
• Liu C, Hong K, Chen H, et al. Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis. Biol Chem. 2019;400(5):651–661. doi: 10.1515/hsz-2018-0204.
   PubMed Web of Science ®Google Scholar
• Finneran DJ, Morgan D, Gordon MN, et al. CNS-wide over expression of fractalkine improves cognitive functioning in a tauopathy model. J Neuroimmune Pharmacol. 2019;14(2):312–325. doi: 10.1007/s11481-018-9822-5.
   PubMed Web of Science ®Google Scholar
• Sosvorova L, Vcelak J, Mohapl M, et al. Selected pro-and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus. Neuroendocrinology Letters. 2014;35(7):586–593.
   PubMed Web of Science ®Google Scholar
• Moreau C, Devos D, Brunaud-Danel V, et al. Elevated IL-6 and TNF-α levels in patients with ALS: inflammation or hypoxia? Neurology. 2005;65(12):1958–1960. doi: 10.1212/01.wnl.0000188907.97339.76.
   PubMed Web of Science ®Google Scholar
• Noda M, Doi Y, Liang J, et al. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J Biol Chem. 2011;286(3):2308–2319. doi: 10.1074/jbc.M110.169839.
   PubMed Web of Science ®Google Scholar
• Chapman GA, Moores K, Harrison D, et al. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci. 2000;20(15):RC87–RC87. doi: 10.1523/JNEUROSCI.20-15-j0004.2000.
   PubMed Web of Science ®Google Scholar
• Fiszman ML, Ricart KC, Latini A, et al. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Acta Neurol Scand. 2010;121(2):120–126. doi: 10.1111/j.1600-0404.2009.01200.x.
   PubMed Web of Science ®Google Scholar
• Ng Kee Kwong KC, Mehta AR, Nedergaard M, et al. Defining novel functions for cerebrospinal fluid in ALS pathophysiology. Acta Neuropathol Commun. 2020;8(1):140–158. doi: 10.1186/s40478-020-01018-0.
   PubMed Web of Science ®Google Scholar
• Sheridan GK, Murphy KJ. Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take Centre stage. Open Biol. 2013;3(12):130181. doi: 10.1098/rsob.130181.
   PubMed Web of Science ®Google Scholar
• Lauro C, Chece G, Monaco L, et al. Fractalkine modulates microglia metabolism in brain ischemia. Front Cell Neurosci. 2019;13:414. doi: 10.3389/fncel.2019.00414.
   PubMed Web of Science ®Google Scholar
• Harrison JK, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A. 1998;95(18):10896–10901. doi: 10.1073/pnas.95.18.10896.
   PubMed Web of Science ®Google Scholar
• Steinacker P, Feneberg E, Halbgebauer S, et al. Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(3-4):276–286. doi: 10.1080/21678421.2020.1861023.
   PubMed Web of Science ®Google Scholar
• Cappello F, Mazzola M, Jurjus A, et al. Hsp60 as a novel target in IBD management: a prospect. Front Pharmacol. 2019;10:26. doi: 10.3389/fphar.2019.00026.
   PubMed Web of Science ®Google Scholar
• Mantej J, Polasik K, Piotrowska E, et al. Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis. Cell Stress Chaperones. 2019;24(1):283–287. doi: 10.1007/s12192-018-0951-9.
   PubMed Web of Science ®Google Scholar
• Chandra D, Choy G, Tang DG. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J Biol Chem. 2007;282(43):31289–31301. doi: 10.1074/jbc.M702777200.
   PubMed Web of Science ®Google Scholar
• Caruso Bavisotto C, Alberti G, Vitale AM, et al. Hsp60 post-translational modifications: functional and pathological consequences. Front Mol Biosci. 2020;7:95. doi: 10.3389/fmolb.2020.00095.
   PubMed Web of Science ®Google Scholar
• Chang D, Sharma L, Cruz CS. Chitotriosidase: a marker and modulator of lung disease. Eur Respir Rev. 2020;29(156):190143. doi: 10.1183/16000617.0143-2019.
   PubMed Web of Science ®Google Scholar